Larimar Therapeutics, Inc. (NASDAQ:LRMR) Receives $19.63 Consensus Price Target from Analysts
Shares of Larimar Therapeutics, Inc. (NASDAQ:LRMR – Get Free Report) have received a consensus rating of “Buy” from the ten research firms that are presently covering the firm, MarketBeat Ratings reports. Nine investment analysts have rated the stock with a buy recommendation and one has issued a strong buy recommendation on the company. The average […]
Shares of Larimar Therapeutics, Inc. (NASDAQ:LRMR – Get Free Report) have received a consensus rating of “Buy” from the ten research firms that are presently covering the firm, MarketBeat Ratings reports. Nine investment analysts have rated the stock with a buy recommendation and one has issued a strong buy recommendation on the company. The average […]
